HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons.

Abstract
Lewy bodies are filamentous neuronal inclusions characteristic of Parkinson's disease, and neurofilament triplet proteins are the major components of the filaments in Lewy bodies. Since the neurofilament proteins found in Lewy bodies are abnormally phosphorylated and partially degraded, the formation of Lewy bodies may be due to the defective metabolism of these proteins, and this could lead to impairments in the structure and function of neurofilament rich neuronal processes (i.e., large caliber axons). To gain further insights into the metabolism of neurofilaments in Parkinson's disease, we evaluated neurofilament mRNA levels by semi-quantitative in situ hybridization histochemistry in postmortem tissues from Parkinson's disease and control subjects. Substantia nigra pars compacta neurons were examined with digoxigenin-UTP labeled cRNA probes to the heavy and light neurofilament mRNAs. The relative abundance of these mRNAs was measured by videodensitometric image analysis of chromogenic reaction product. Using this approach, we demonstrated that the levels of both heavy and light neurofilament mRNAs were reduced in Parkinson's disease substantia nigra pars compacta neurons. Additionally, the levels of heavy neurofilament mRNA were lowest in Lewy body containing neurons in the Parkinson's disease cases. These results suggest that the formation of neurofilament-rich Lewy bodies in substantia nigra pars compacta neurons is associated with reduced levels of the heavy and light neurofilament mRNAs in Parkinson's disease. Thus, it is possible that the accumulation of abnormal neurofilament proteins in Lewy bodies and diminished neurofilament mRNAs contribute to the degeneration of substantia nigra pars compacta neurons in Parkinson's disease.
AuthorsW D Hill, M Arai, J A Cohen, J Q Trojanowski
JournalThe Journal of comparative neurology (J Comp Neurol) Vol. 329 Issue 3 Pg. 328-36 (Mar 15 1993) ISSN: 0021-9967 [Print] United States
PMID8459049 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Melanins
  • Neurofilament Proteins
  • RNA, Messenger
  • Digoxigenin
  • Uridine Triphosphate
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Aging (metabolism)
  • Animals
  • Digoxigenin (metabolism)
  • Female
  • Histocytochemistry
  • Humans
  • Image Processing, Computer-Assisted
  • In Situ Hybridization
  • Lewy Bodies (pathology)
  • Male
  • Melanins (metabolism)
  • Mice
  • Middle Aged
  • Neurofilament Proteins (biosynthesis)
  • Neurons (metabolism)
  • Parkinson Disease (metabolism, pathology)
  • RNA, Messenger (biosynthesis)
  • Substantia Nigra (metabolism, pathology)
  • Uridine Triphosphate (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: